News Conference News ACC 2026 DIG-RHD: Digoxin Effective in Rheumatic Heart Disease Michael O'Riordan April 06, 2026
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017